OQROGet OQRO Pro
Insider trade

Mink Therapeutics (INKT)Director sold ~$7.7K

Barbara Ryan, Director at Mink Therapeutics, sold ~$7.7K of Mink Therapeutics shares.

~$7.7K
Approx. value · 500 sh @ $15.30
20K
Holds after · shares reported
Traded
Mar 10, 2026
Filed
Mar 11, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 27, 2026InsiderDirector sold ~$4.3K of INKT shares in the open market
  2. Mar 2, 2026InsiderDirector sold ~$1.1K of INKT shares in the open market
  3. Mar 9, 2026InsiderDirector sold ~$2K of INKT shares in the open market
  4. Mar 10, 2026 · this disclosureInsiderDirector sold ~$7.7K of INKT shares in the open market

What came next

  1. Mar 10, 2026Insider · 1 personInsiders: 2 sales (~$12K)
  2. Mar 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“Effective March 13, 2026, MiNK Therapeutics Inc.'s (the “Company”) Board of Directors appointed Melissa Orilall, Agenus Inc.'s ("Agenus") current Vice President, Global Financial Operations to serve as the Company's Principal Financial Officer.”
  3. Mar 31, 2026Company filing · Form 8-K · ResultsReported its results
  4. May 15, 2026Company filing · Form 8-K · ResultsReported its results
  5. Jun 4, 2026Insider · 1 personInsiders: 2 sales (~$19K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Mink Therapeutics

OQRO holds no insider, Congress, fund or contract record for Mink Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INKT page.

Other recent filings by Barbara Ryan, Director

The full history of Barbara Ryan, Director is on the profile page.

How this filing works

Other disclosures at Mink Therapeutics

Everything OQRO holds on this company is on its INKT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data